Abstract:Osteoporosis, characterized by deteriorated bone microarchitecture and low bone mineral density, is a chronic skeletal disease with high worldwide prevalence. Osteoporosis related to aging is the most common form and causes significant morbidity and mortality. Rare, monogenic forms of osteoporosis have their onset usually in childhood or young adulthood and have specific phenotypic features and clinical course depending on the underlying cause. The most common form is osteogenesis imperfecta linked to mutations in COL1A1 and COL1A2, the two genes encoding type I collagen. However, in the past years, remarkable advancements in bone research have expanded our understanding of the intricacies behind bone metabolism and identified novel molecular mechanisms contributing to skeletal health and disease. Especially high-throughput sequencing techniques have made family-based studies an efficient way to identify single genes causative of rare monogenic forms of osteoporosis and these have yielded several novel genes that encode proteins partaking in type I collagen modification or regulating bone cell function directly. New forms of monogenic osteoporosis, such as autosomal dominant osteoporosis caused by WNT1 mutations or X-linked osteoporosis due to PLS3 mutations, have revealed previously unidentified bone-regulating proteins and clarified specific roles of bone cells, expanded our understanding of possible inheritance mechanisms and paces of disease progression, and highlighted the potential of monogenic bone diseases to extend beyond the skeletal tissue. The novel gene discoveries have introduced new challenges to the classification and diagnosis of monogenic osteoporosis, but also provided promising new molecular targets for development of pharmacotherapies. In this article we give an overview of the recent discoveries in the area of monogenic forms of osteoporosis, describing the key cellular mechanisms leading to skeletal fragility, the major recent research findings and the essential challenges and avenues in future diagnostics and treatments.

Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene

Early‐onset osteoporosis: Rare monogenic forms elucidate the complexity of disease pathogenesis beyond type I collagen

Identification of a Novel Splicing Mutation and Genotype-Phenotype Correlations in Rare PLS3-related Childhood-Onset Osteoporosis

Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties

A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis

PLS3 Gene Variation in Childhood Fractures and Primary Osteoporosis

PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization

A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid

A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family

PLS3 mutations in X-linked osteoporosis with fractures

Idiopathic juvenile osteoporosis-a polygenic disorder?

Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2

LRP5 Variant Without Pseudoglioma in a Young Man With Fragility Fractures

The intricate mechanism of PLS3 in bone homeostasis and disease

Genetics of osteoporosis: searching for candidate genes for bone fragility

New Insights Into Monogenic Causes of Osteoporosis

Functional Analysis of p.Ala253_Leu254insAsn Mutation in PLS3 Responsible for X-linked Osteoporosis.

Bone fragility and osteoporosis in children and young adults

Plastin 3 influences bone homeostasis through regulation of osteoclast activity

Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta

Genetic Variants in the PLS3 Gene Are Associated with Osteoporotic Fractures in Postmenopausal Chinese Women.